Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Gudas Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Affiliations
Job Opportunities
Contact Us
Research
Toggle Research menu options
Projects
Lab Team
Toggle Lab Team menu options
Lab Activities
Toggle Lab Activities menu options
Activities
Celebrations
Seminars
Lab Presentations & Meetings
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Research
Lab Team
Publications
Home
Publications
Publications
Found 5 results
Author
Title
Type
Year
Filters:
Author
is
O'Donovan, Tracey R
[Clear All Filters]
2022
Benjamin DN
,
O'Donovan TR
,
Laursen KB
,
Orfali N
,
Cahill MR
,
Mongan NP
,
Gudas LJ
,
McKenna SL
. 2022.
All-Trans-Retinoic Acid Combined With Valproic Acid Can Promote Differentiation in Myeloid Leukemia Cells by an Autophagy Dependent Mechanism.
.
Front Oncol. 12:848517.
2020
Orfali N
,
O'Donovan TR
,
Cahill MR
,
Benjamin D
,
Nanus DM
,
McKenna SL
,
Gudas LJ
,
Mongan NP
. 2020.
All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
.
Eur J Haematol. 104(3):236-250.
2019
Orfali N
,
Shan-Krauer D
,
O'Donovan TR
,
Mongan NP
,
Gudas LJ
,
Cahill MR
,
Tschan MP
,
McKenna SL
. 2019.
Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells.
.
Mol Oncol.
Orfali N
,
Jeyapalan JN
,
Woodcock CL
,
O'Donovan TR
,
Benjamin D
,
Cahill M
,
McKenna S
,
Gudas LJ
,
Mongan NP
. 2019.
Lentiviral-Mediated shRNA Approaches: Applications in Cellular Differentiation and Autophagy.
.
Methods Mol Biol. 2019:33-49.
2015
Orfali N
,
O'Donovan TR
,
Nyhan MJ
,
Britschgi A
,
Tschan MP
,
Cahill MR
,
Mongan NP
,
Gudas LJ
,
McKenna SL
. 2015.
Induction of autophagy is a key component of all-trans-retinoic acid-induced differentiation in leukemia cells and a potential target for pharmacologic modulation.
.
Exp Hematol. 43(9):781-93.e2.